Symptom Preoccupation in Atrial Fibrillation (AF) and Its Role in AF-related Disability
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT04123327
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
A cross-sectional study (N=400) will investigate the prevalence of symptom preoccupation and its role in AF-related disability. Subjectively-rated assessments will be gathered from 400 AF patients.
- Detailed Description
In the present study we aim to investigate symptom preoccupation in patients with atrial fibrillation (AF) to further improve the understanding of the role of psychological factors in AF-related disability. A cross-sectional study (N=400) will investigate the prevalence of symptom preoccupation and its role in AF-related disability. Subjectively-rated assessments will be gathered from 400 AF patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
- 18 years of age
- Diagnoses with AF
- Able to read Swedish and access to computer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method [Time Frame: From baseline to 12 weeks] Atrial Fibrillation Effect on Quality-of-Life (AFEQT) Baseline AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction. The scale has 20 items, with the total score ranging from 0 (severe symptoms and disability) to 100 (no symptoms and disability), with responses provided on a seven-point rating scale from "no limitations/symptoms" to "severe limitations/symptoms".
- Secondary Outcome Measures
Name Time Method Demographics Baseline Demographics
Bodily Sensation Questionnaire (BSQ) Baseline Fear of bodily sensations
Cardiac Anxiety Questionnaire (CAQ) Baseline It an 18-item scale that measures cardiac anxiety by three subscales fear (e.g., "When my heart is beating fast I get frightened" avoidance (e.g., I avoid exercise or other physical work) and attention (e.g., I pay attention to my heart beat). The responses are given on a four-point Likert scale ranging from 0 (never) to 4 (always), a greater score indicates greater cardiac anxiety.
Patient Health Questionnaire (PHQ-9) Baseline Measures depressive symptoms on nine items scoring from 0 (not at all) to 3 (nearly every day) per item. Scores were categorized as follows: zero to minimal depressive symptoms (0-4), mild to moderate depressive symptoms (5-10), or severe depressive symptoms (10 or above).
The Generalized Anxiety Disorder (GAD-7) Baseline The Generalized Anxiety Disorder (GAD-7) scale measures the severity of worry and anxiety. In healthy controls, the mean score was 4.9 (SD=4.8); a score of 10 or greater on the scale corresponds to a cut-off point for identifying cases of GAD.
Anxiety Sensitivity Index (ASI) Baseline Measure of anxiety sensitivity
The University of Toronto Atrial Fibrillation Severity Scale (AFSS) Baseline AFSS will assess AF symptoms and how affected the patient is by AF-specific symptoms such as dyspnea, palpitations etc. The AF symptom score ranges from 0-35 with a higher score indicating higher symptom severity.
The Symptoms Checklist, Frequency and Severity Scale (SCL) Baseline SCL is a disease specific checklist used to measure AF-related symptoms (e.g., palpitations, dizziness) on two subscales: symptom severity (mild to extreme; 16 items, scores ranging from 0 to 48) and symptom frequency (never to always; 16 items, scores ranging from 0 to 64) over the past four weeks. Higher scores correlate with more frequent and severe symptoms.
Perceived Stress Scale (PSS-4) Baseline To assess stress sensitivity and perception of stress. Each item is rated on a five-point scale and a higher score corresponds to more perceived stress.
World Health Organization Disability Assessment Schedule (WHODAS) Baseline WHODAS is a reliable and well validated measure of general health and disability. We use the version consisting of 12-items evaluating six domains: cognition, mobility, self-care, getting along, life activities and life participation. Each item is rated on a 5-point scale, with higher scores indicating increased disability.
AF behaviors Baseline Checklist of behaviors related to AF
Medical history Baseline Comorbidities, medication, medical history
Trial Locations
- Locations (1)
Department of Clinical Neuroscience, Karolinska Institutet
🇸🇪Stockholm, Sweden